Insider Trading History of Cohen Marc A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Cohen Marc A since 2007. This trader's CIK number is 1132945. At the time of last reporting, Cohen Marc A was the Director of C4 Therapeutics, Inc.. (stock ticker symbol CCCC). Also see all insider trading activities at C4 Therapeutics, Inc..

Note that in the past COHEN MARC A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Frequency Therapeutics, Inc. (FREQ) by Cohen Marc A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 FREQ 0 $0 0 $0 88,116 $199,670
2019 FREQ 17,857 $249,998 0 $0 0 $0

Yearly summary of insider trading at Opnet Technologies Inc (OPNT) by Cohen Marc A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 OPNT 0 $0 24,323 $595,971 98,000 $856,500
2011 OPNT 0 $0 0 $0 100,000 $1,059,000
2010 OPNT 0 $0 77,105 $1,197,415 75,000 $936,540
2009 OPNT 0 $0 1,115 $10,474 0 $0
2007 OPNT 53,534 $466,799 0 $0 0 $0

Yearly summary of insider trading at C4 Therapeutics, Inc. (CCCC) by Cohen Marc A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 CCCC 0 $0 0 $0 536 $1,130
2020 CCCC 5,030 $95,570 0 $0 0 $0


Insider trading activities at 3 companies by Cohen Marc A:

1. Frequency Therapeutics, Inc. (FREQ)

2. Opnet Technologies Inc (OPNT)

3. C4 Therapeutics, Inc. (CCCC)

Table 1. Insider trading of Frequency Therapeutics, Inc. (FREQ) by Cohen Marc A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-01-30 FREQ Option Ex 88,116 2.27 199,670
2019-10-07 FREQ Buy 17,857 14.00 249,998

Table 2. Insider trading of Opnet Technologies Inc (OPNT) by Cohen Marc A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-11-14 OPNT Option Ex 48,000 11.75 564,000
2012-06-14 OPNT Sale 12,323 24.68 304,131
2012-06-13 OPNT Sale 12,000 24.32 291,840
2012-06-14 OPNT Option Ex 38,000 5.85 222,300
2012-06-13 OPNT Option Ex 12,000 5.85 70,200
2011-07-14 OPNT Option Ex 100,000 10.59 1,059,000
2010-07-27 OPNT Sale 250 15.15 3,787
2010-06-15 OPNT Option Ex 5,450 13.20 71,940
2010-06-15 OPNT Sale 5,450 15.67 85,401
2010-06-14 OPNT Option Ex 20,000 13.20 264,000
2010-06-14 OPNT Sale 20,000 15.69 313,800
2010-06-11 OPNT Option Ex 10,000 12.60 126,000
2010-06-10 OPNT Option Ex 10,000 12.00 120,000
2010-06-11 OPNT Sale 10,000 15.22 152,200
2010-06-10 OPNT Sale 10,000 15.29 152,900
2010-06-09 OPNT Sale 10,000 15.26 152,600
2010-06-08 OPNT Option Ex 2,750 12.00 33,000
2010-06-09 OPNT Option Ex 10,000 12.00 120,000
2010-06-08 OPNT Sale 2,750 15.23 41,882
2010-06-04 OPNT Option Ex 550 12.00 6,600
2010-06-04 OPNT Sale 550 15.76 8,668
2010-06-03 OPNT Sale 8,750 15.92 139,300
2010-06-02 OPNT Sale 7,500 15.97 119,775
2010-06-03 OPNT Option Ex 8,750 12.00 105,000
2010-06-02 OPNT Option Ex 7,500 12.00 90,000
2010-06-01 OPNT Sale 298 15.50 4,619
2010-04-27 OPNT Sale 314 16.97 5,328
2010-02-22 OPNT Sale 268 14.50 3,886
2010-02-08 OPNT Sale 975 13.61 13,269
2009-10-26 OPNT Sale 228 10.14 2,311
2009-07-27 OPNT Sale 250 8.98 2,245
2009-06-01 OPNT Sale 323 10.45 3,375
2009-04-27 OPNT Sale 314 8.10 2,543
2007-11-20 OPNT Buy 8,885 8.74 77,628
2007-11-19 OPNT Buy 9,800 8.65 84,779
2007-11-16 OPNT Buy 9,100 8.53 77,650
2007-11-15 OPNT Buy 8,683 8.59 74,552
2007-11-14 OPNT Buy 8,666 8.74 75,784
2007-11-13 OPNT Buy 8,400 9.10 76,406

Table 3. Insider trading of C4 Therapeutics, Inc. (CCCC) by Cohen Marc A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-18 CCCC Option Ex 536 2.11 1,130
2020-10-06 CCCC Buy 5,030 19.00 95,570

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cohen Marc A (Director of C4 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.